Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion type Assertion NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_head.
- NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion description "[ABCG2 was preferentially expressed in highly chemoresistant hepatocellular carcinoma cancer stem cells (CSC) enriched with CD133.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_provenance.
- NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion evidence source_evidence_literature NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_provenance.
- NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion SIO_000772 24130050 NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_provenance.
- NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion wasDerivedFrom befree-2016 NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_provenance.
- NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_assertion wasGeneratedBy ECO_0000203 NP1119702.RAAhcEUAtaALIHYqteQO2wqp9z-vmGESiUQGvin6z9E3A130_provenance.